4.6 Article

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Ovarian Cancer Statistics, 2018

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Oncology

Cancer Statistics, 2016

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Review Reproductive Biology

Adoptive immunotherapy against ovarian cancer

Gloria Mittica et al.

JOURNAL OF OVARIAN RESEARCH (2016)

Review Immunology

γδ T Cells: First Line of Defense and Beyond

Yueh-hsiu Chien et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Article Oncology

Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer

S. John Weroha et al.

CLINICAL CANCER RESEARCH (2014)

Review Oncology

Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer

Pierre-Emmanuel Colombo et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)

Review Immunology

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Jean-Jacques Fournie et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2013)

Article Oncology

Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes

Dongmei Lai et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)

Article Oncology

Anticancer Properties of Zoledronic Acid

Jonathan Green et al.

CANCER INVESTIGATION (2010)